Community Guide
Growth Hormone Peptides: What the Community Uses
Growth hormone secretagogues stimulate the pituitary to produce and release GH rather than replacing it directly. Community accounts have accumulated around a consistent set of compounds — this page surfaces what those reports describe about protocols, effects, and what goes wrong.
GHRH analogues vs GHRPs: what community accounts describe
Community accounts distinguish between two classes of GH peptides with different mechanisms. GHRH analogues (CJC-1295, sermorelin, tesamorelin) work by amplifying the body's natural GHRH signal — they increase the amplitude of GH pulses. GHRP-class peptides (ipamorelin, GHRP-2, GHRP-6, hexarelin) work by triggering GH release through the ghrelin receptor. Community accounts consistently describe the combination as synergistic — a GHRH analogue + a GHRP produces a larger GH pulse than either alone. This is the mechanistic basis for the CJC-1295 + ipamorelin stack that dominates community protocols.
CJC-1295: with DAC vs without DAC
The most consequential choice in GH peptide accounts: CJC-1295 with DAC (Drug Affinity Complex) vs without. CJC-1295 without DAC (also called Modified GRF 1-29) has a short half-life of 30 minutes — it must be dosed daily or multiple times daily, timed around GH pulses. CJC-1295 with DAC has a half-life of 6–8 days — dosed once or twice weekly. Community accounts using the DAC version describe the tradeoff: convenience vs control. Accounts preferring without-DAC describe better ability to time GH pulses (before sleep, before training) and cleaner results. DAC accounts describe easier compliance and consistent background GH elevation.
Ipamorelin: why it dominates modern accounts
Ipamorelin has largely replaced older GHRP-class peptides (GHRP-2, GHRP-6) in community accounts. The reason cited consistently: ipamorelin does not trigger significant cortisol or prolactin release, which older GHRPs do. GHRP-6 accounts in particular describe intense hunger spikes — a side effect absent from ipamorelin accounts. Hexarelin accounts describe it as the most potent GHRP but with the highest cortisol elevation. The community consensus: ipamorelin is the clean GHRP — most of the GH release benefit with the lowest side effect burden of the class.
MK-677: the oral alternative
MK-677 (ibutamoren) occupies a unique position in GH peptide accounts: it is orally bioavailable. Accounts drawn to MK-677 cite injection avoidance as the primary motivator. The tradeoffs described: hunger (described as significant and difficult to manage in most accounts), water retention in the first 4–8 weeks, and vivid dreams. MK-677 accounts at 25mg daily describe GH and IGF-1 elevation consistent with injectable GH peptide protocols. Accounts running MK-677 for extended periods (6–12 months) describe stable results without receptor desensitization. The cortisol elevation concern from older GHRPs is largely absent from MK-677 accounts.
Sleep, water retention, and what to expect
Two side effects appear in the majority of GH secretagogue accounts regardless of compound: vivid dreams and water retention. Vivid dreams appear in the first 2–4 weeks of dosing before sleep — described by most accounts as neutral to positive, occasionally disruptive. Water retention is consistent across the first 4–8 weeks, described as puffiness rather than functional edema, subsiding as the body adjusts. Body composition results from GH peptides in community accounts take time — accounts consistently describe 8–12 weeks as the minimum before meaningful changes in fat distribution or muscle fullness. Accounts expecting faster results describe disappointment; accounts with realistic timelines describe consistent satisfaction.
Related peptides:
Browse topics:
Community Q&A
- What is the best growth hormone peptide?
- By community account consensus: CJC-1295 without DAC + ipamorelin is the most consistently recommended GH secretagogue stack. The combination is described as synergistic, with ipamorelin cited as the cleanest GHRP (no cortisol or hunger spikes). MK-677 is recommended in accounts where injections are a barrier — oral administration at the cost of hunger and water retention. Sermorelin appears in accounts from users seeking a more conservative, shorter-acting GHRH analogue.
- How long does it take for GH peptides to work?
- Community accounts are consistent: 8–12 weeks minimum for meaningful body composition changes. Sleep quality improvements appear in most accounts within 1–2 weeks. Water retention appears and subsides in the first 4–8 weeks. Fat loss and muscle changes emerge gradually — accounts that measured body composition before and after 12-week cycles describe consistent improvements; accounts looking for results at 4 weeks describe disappointment.
- What is the difference between CJC-1295 and ipamorelin?
- CJC-1295 is a GHRH analogue — it amplifies the pituitary's response to growth hormone-releasing hormone. Ipamorelin is a GHRP — it triggers GH release through the ghrelin receptor. The two mechanisms are complementary: community accounts describe the combination as producing larger GH pulses than either compound alone. CJC-1295 is available with DAC (long half-life, weekly dosing) or without DAC (short half-life, daily dosing). Ipamorelin is always short-acting, dosed daily.
- Does MK-677 really increase growth hormone?
- Community accounts consistently describe meaningful increases in IGF-1 (the measurable proxy for GH elevation) on MK-677 at 25mg daily. Bloodwork accounts pre- and post-MK-677 describe IGF-1 increases of 50–150% from baseline in most reports. The tradeoffs — persistent hunger, water retention, vivid dreams — are described as real but manageable. Accounts running MK-677 for 6–12 months describe sustained IGF-1 elevation without apparent desensitization.
- Should I dose GH peptides before bed?
- Community accounts strongly favor pre-sleep dosing. The rationale cited: the largest natural GH pulse occurs during deep sleep (approximately 1 hour after sleep onset), and GH secretagogues timed to coincide with this pulse amplify rather than disrupt the natural pattern. Accounts dosing at other times describe results, but the pre-sleep protocol is the community standard. MK-677 accounts describe dosing at dinner or immediately before bed to blunt the hunger window.